AU Patent

AU2019203745B2 — Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds

Assigned to Exelixis Inc · Expires 2020-09-03 · 6y expired

What this patent protects

The present invention is directed to processes for making and compositions containing quinolines such as formula I or pharmaceutically acceptable salts thereof: (X2) H H n2 N O ONX H 3C H 3C-O QN wherein: X 1 is H, Br, Cl, or F; X2 is H, Br, Cl, or F; nl is 1-2; and n2 i…

USPTO Abstract

The present invention is directed to processes for making and compositions containing quinolines such as formula I or pharmaceutically acceptable salts thereof: (X2) H H n2 N O ONX H 3C H 3C-O QN wherein: X 1 is H, Br, Cl, or F; X2 is H, Br, Cl, or F; nl is 1-2; and n2 is 1-2. 47

Drugs covered by this patent

Patent Metadata

Patent number
AU2019203745B2
Jurisdiction
AU
Classification
Expires
2020-09-03
Drug substance claim
No
Drug product claim
No
Assignee
Exelixis Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.